Washington, D.C.–(ENEWSPF)–June 18, 2010. Major news: It was announced today that Sativex, a cannabinoid-based liquid medicine sprayed under the tongue, has been approved for use in Great Britain to help treat the muscle spasticity suffered by multiple sclerosis patients. Sativex is a natural marijuana extract that is produced by British-based GW Pharmaceuticals. It has been approved for use in Canada to treat neuropathic pain since 2005.
